The Discounted Cash Flow (DCF) valuation of Surgical Science Sweden AB (SUS.ST) is 96.54 SEK. With the latest stock price at 153.40 SEK, the upside of Surgical Science Sweden AB based on DCF is -37.1%.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.0% | 6.8% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 64.47 - 258.13 | 96.54 |
| Upside | -58.0% - 68.3% | -37.1% |